Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects

NCT01660295 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Insufficiency

Interventions

DRUG: Certoparin 3,000 IU Once Daily
DRUG: Certoparin 3,000 IU Twice a Day
DRUG: Certoparin 8,000 IU Once Daily
DRUG: Certoparin 8,000 IU Twice a Day

Sponsor

Novartis Pharmaceuticals